PortfoliosLab logo
MEDP vs. ATEC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MEDP and ATEC is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

MEDP vs. ATEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and Alphatec Holdings, Inc. (ATEC). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%1,200.00%NovemberDecember2025FebruaryMarchApril
979.03%
132.70%
MEDP
ATEC

Key characteristics

Sharpe Ratio

MEDP:

-0.61

ATEC:

-0.36

Sortino Ratio

MEDP:

-0.62

ATEC:

-0.04

Omega Ratio

MEDP:

0.91

ATEC:

0.99

Calmar Ratio

MEDP:

-0.66

ATEC:

-0.30

Martin Ratio

MEDP:

-1.21

ATEC:

-0.74

Ulcer Index

MEDP:

21.42%

ATEC:

37.88%

Daily Std Dev

MEDP:

42.44%

ATEC:

78.14%

Max Drawdown

MEDP:

-42.87%

ATEC:

-98.90%

Current Drawdown

MEDP:

-33.84%

ATEC:

-90.67%

Fundamentals

Market Cap

MEDP:

$9.15B

ATEC:

$1.45B

EPS

MEDP:

$12.62

ATEC:

-$1.13

PEG Ratio

MEDP:

1.65

ATEC:

0.00

Total Revenue (TTM)

MEDP:

$1.60B

ATEC:

$417.88M

Gross Profit (TTM)

MEDP:

$493.93M

ATEC:

$307.03M

EBITDA (TTM)

MEDP:

$364.06M

ATEC:

-$29.57M

Returns By Period

In the year-to-date period, MEDP achieves a -8.93% return, which is significantly lower than ATEC's 9.48% return.


MEDP

YTD

-8.93%

1M

-10.33%

6M

-11.36%

1Y

-25.25%

5Y*

29.59%

10Y*

N/A

ATEC

YTD

9.48%

1M

3.93%

6M

89.27%

1Y

-29.52%

5Y*

20.67%

10Y*

-5.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MEDP vs. ATEC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
The Risk-Adjusted Performance Rank of MEDP is 2626
Overall Rank
The Sharpe Ratio Rank of MEDP is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 2929
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 2828
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 1717
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 3131
Martin Ratio Rank

ATEC
The Risk-Adjusted Performance Rank of ATEC is 4343
Overall Rank
The Sharpe Ratio Rank of ATEC is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of ATEC is 4444
Sortino Ratio Rank
The Omega Ratio Rank of ATEC is 4444
Omega Ratio Rank
The Calmar Ratio Rank of ATEC is 4141
Calmar Ratio Rank
The Martin Ratio Rank of ATEC is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MEDP vs. ATEC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Alphatec Holdings, Inc. (ATEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for MEDP, currently valued at -0.61, compared to the broader market-2.00-1.000.001.002.00
MEDP: -0.61
ATEC: -0.36
The chart of Sortino ratio for MEDP, currently valued at -0.62, compared to the broader market-6.00-4.00-2.000.002.004.00
MEDP: -0.62
ATEC: -0.04
The chart of Omega ratio for MEDP, currently valued at 0.91, compared to the broader market0.501.001.502.00
MEDP: 0.91
ATEC: 0.99
The chart of Calmar ratio for MEDP, currently valued at -0.66, compared to the broader market0.001.002.003.004.00
MEDP: -0.66
ATEC: -0.38
The chart of Martin ratio for MEDP, currently valued at -1.21, compared to the broader market-10.000.0010.0020.00
MEDP: -1.21
ATEC: -0.74

The current MEDP Sharpe Ratio is -0.61, which is lower than the ATEC Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of MEDP and ATEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.61
-0.36
MEDP
ATEC

Dividends

MEDP vs. ATEC - Dividend Comparison

Neither MEDP nor ATEC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MEDP vs. ATEC - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum ATEC drawdown of -98.90%. Use the drawdown chart below to compare losses from any high point for MEDP and ATEC. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-33.84%
-46.54%
MEDP
ATEC

Volatility

MEDP vs. ATEC - Volatility Comparison

The current volatility for Medpace Holdings, Inc. (MEDP) is 14.48%, while Alphatec Holdings, Inc. (ATEC) has a volatility of 16.61%. This indicates that MEDP experiences smaller price fluctuations and is considered to be less risky than ATEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%NovemberDecember2025FebruaryMarchApril
14.48%
16.61%
MEDP
ATEC

Financials

MEDP vs. ATEC - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Alphatec Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items